KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Astrazeneca (AZN) FCF Margin (2016 - 2025)

Historic FCF Margin for Astrazeneca (AZN) over the last 15 years, with Q4 2025 value amounting to 27.59%.

  • Astrazeneca's FCF Margin fell 34700.0% to 27.59% in Q4 2025 from the same period last year, while for Dec 2025 it was 36.68%, marking a year-over-year increase of 36700.0%. This contributed to the annual value of 36.68% for FY2025, which is 36700.0% up from last year.
  • Latest data reveals that Astrazeneca reported FCF Margin of 27.59% as of Q4 2025, which was down 34700.0% from 45.49% recorded in Q3 2025.
  • Over the past 5 years, Astrazeneca's FCF Margin peaked at 1501.16% during Q1 2022, and registered a low of 2.52% during Q4 2021.
  • For the 5-year period, Astrazeneca's FCF Margin averaged around 122.02%, with its median value being 33.28% (2024).
  • Per our database at Business Quant, Astrazeneca's FCF Margin surged by 14646500bps in 2022 and then crashed by -14656600bps in 2023.
  • Astrazeneca's FCF Margin (Quarter) stood at 2.52% in 2021, then skyrocketed by 809bps to 22.94% in 2022, then increased by 16bps to 26.72% in 2023, then increased by 16bps to 31.06% in 2024, then decreased by -11bps to 27.59% in 2025.
  • Its last three reported values are 27.59% in Q4 2025, 45.49% for Q3 2025, and 37.57% during Q2 2025.